BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$872M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$311M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$169M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$169M |
| 2 |
CELG
Celgene Corp
CELG
|
+$148M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$134M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$121M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$83.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.92% |
| 2 | Financials | 6.08% |
| 3 | Healthcare | 5.28% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Communication Services | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Enpro
NPO
$7.22B
| $306K | ﹤0.01% |
4,748
+3,444
| +264% | +$227K |
|
2327
Piper Sandler
PIPR
$5.45B
| $306K | ﹤0.01% |
16,800
+8,736
| +108% | +$155K |
|
|
DOOR
2328
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $305K | ﹤0.01% |
6,120
+5,225
| +584% | +$278K |
|
2329
Medpace
MEDP
$16.2B
| $305K | ﹤0.01% |
5,169
+4,915
| +1,935% | +$294K |
|
2330
Stellantis
STLA
$20.2B
| $304K | ﹤0.01% |
20,466
-60,307
| -75% | -$927K |
|
|
BRSP
2331
BrightSpire Capital
BRSP
$634M
| $304K | ﹤0.01% |
19,400
+14,417
| +289% | +$237K |
|
2332
Hilltop Holdings
HTH
$2.27B
| $303K | ﹤0.01% |
16,601
+14,839
| +842% | +$276K |
|
|
CVGW
2333
DELISTED
Calavo Growers
CVGW
| $303K | ﹤0.01% |
3,612
+3,270
| +956% | +$265K |
|
2334
Employers Holdings
EIG
$873M
| $303K | ﹤0.01% |
7,545
+5,074
| +205% | +$214K |
|
|
RDS.A
2335
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $302K | ﹤0.01% |
4,831
-93,062
| -95% | -$5.75M |
|
2336
Park National Corp
PRK
$3.77B
| $302K | ﹤0.01% |
3,191
+2,033
| +176% | +$195K |
|
2337
Sanofi
SNY
$105B
| $302K | ﹤0.01% |
6,821
+3,951
| +138% | +$169K |
|
|
BOLD
2338
DELISTED
Audentes Therapeutics, Inc
BOLD
| $302K | ﹤0.01% |
7,730
+7,505
| +3,336% | +$215K |
|
|
CBM
2339
DELISTED
Cambrex Corporation
CBM
| $301K | ﹤0.01% |
7,750
+5,917
| +323% | +$242K |
|
|
CSII
2340
DELISTED
Cardiovascular Systems, Inc.
CSII
| $301K | ﹤0.01% |
7,781
+7,040
| +950% | +$239K |
|
2341
Varex Imaging
VREX
$779M
| $300K | ﹤0.01% |
8,868
+7,154
| +417% | +$216K |
|
2342
Gentherm
THRM
$1.34B
| $300K | ﹤0.01% |
8,135
+5,392
| +197% | +$219K |
|
|
CEO
2343
DELISTED
CNOOC Limited
CEO
| $299K | ﹤0.01% |
1,607
-228
| -12% | -$38.6K |
|
2344
Rush Enterprises Class A
RUSHA
$9.56B
| $298K | ﹤0.01% |
16,034
+10,861
| +210% | +$192K |
|
2345
Safety Insurance
SAFT
$1.52B
| $298K | ﹤0.01% |
3,415
+2,262
| +196% | +$194K |
|
|
HA
2346
DELISTED
Hawaiian Holdings, Inc.
HA
| $297K | ﹤0.01% |
11,323
+6,869
| +154% | +$199K |
|
2347
OFG Bancorp
OFG
$2.25B
| $296K | ﹤0.01% |
14,968
+9,003
| +151% | +$174K |
|
2348
Dycom Industries
DY
$12.5B
| $296K | ﹤0.01% |
6,446
+5,830
| +946% | +$319K |
|
2349
Stride
LRN
$3.45B
| $296K | ﹤0.01% |
8,662
+5,209
| +151% | +$159K |
|
2350
BJ's Restaurants
BJRI
$1.42B
| $296K | ﹤0.01% |
6,252
+3,085
| +97% | +$155K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2019 Portfolio in Review
As of Q1 2019, BNP Paribas Financial Markets held 4,541 positions worth $46.3B, up 9.3% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $4.24B of net new capital in Q1 2019, opening 207 new positions and adding to 2,771 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 7.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $169M trimmed.
- BNP Paribas Financial Markets's largest Q1 2019 buy was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2019, an estimated $1.31B increase.
- BNP Paribas Financial Markets's biggest Q1 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $169M.
- BNP Paribas Financial Markets fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $37.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $46.3B portfolio in Q1 2019.
- BNP Paribas Financial Markets opened 207 new positions and closed 255 in Q1 2019.
- BNP Paribas Financial Markets's portfolio value rose 9.3% quarter-over-quarter to $46.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.